These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 20116383)

  • 21. Fibroblast growth factor-2-induced cardioprotection against myocardial infarction occurs via the interplay between nitric oxide, protein kinase signaling, and ATP-sensitive potassium channels.
    Manning JR; Carpenter G; Porter DR; House SL; Pietras DA; Doetschman T; Schultz Jel J
    Growth Factors; 2012 Apr; 30(2):124-39. PubMed ID: 22304432
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuroprotective effects of LMW and HMW FGF2 against amyloid beta toxicity in primary cultured hippocampal neurons.
    Cheng Y; Li Z; Kardami E; Loh YP
    Neurosci Lett; 2016 Oct; 632():109-13. PubMed ID: 27546824
    [TBL] [Abstract][Full Text] [Related]  

  • 23. FGF2 isoforms play distinct roles in tubular epithelial-to-mesenchymal transition in diabetic nephropathy.
    Luo Y; Deng D; Lin L; Zhou Y; Wang L; Zou X; Wang X
    Exp Cell Res; 2022 Nov; 420(2):113355. PubMed ID: 36115414
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High- but not low-molecular weight FGF-2 causes cardiac hypertrophy in vivo; possible involvement of cardiotrophin-1.
    Jiang ZS; Jeyaraman M; Wen GB; Fandrich RR; Dixon IM; Cattini PA; Kardami E
    J Mol Cell Cardiol; 2007 Jan; 42(1):222-33. PubMed ID: 17045289
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High molecular weight FGF2: the biology of a nuclear growth factor.
    Chlebova K; Bryja V; Dvorak P; Kozubik A; Wilcox WR; Krejci P
    Cell Mol Life Sci; 2009 Jan; 66(2):225-35. PubMed ID: 18850066
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Blockade of Hsp20 phosphorylation exacerbates cardiac ischemia/reperfusion injury by suppressed autophagy and increased cell death.
    Qian J; Ren X; Wang X; Zhang P; Jones WK; Molkentin JD; Fan GC; Kranias EG
    Circ Res; 2009 Dec; 105(12):1223-31. PubMed ID: 19850943
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Elimination or neutralization of endogenous high-molecular-weight FGF2 mitigates doxorubicin-induced cardiotoxicity.
    Koleini N; Santiago JJ; Nickel BE; Sequiera GL; Wang J; Fandrich RR; Jassal DS; Dhingra S; Kirshenbaum LA; Cattini PA; Kardami E
    Am J Physiol Heart Circ Physiol; 2019 Feb; 316(2):H279-H288. PubMed ID: 30412444
    [TBL] [Abstract][Full Text] [Related]  

  • 28. FGF-2 isoforms influence the development of dopaminergic neurons in the murine substantia nigra, but not anxiety-like behavior, stress susceptibility, or locomotor behavior.
    Hövel FFV; Leiter I; Rumpel R; Langenhagen A; Wedekind D; Häger C; Bleich A; Palme R; Grothe C
    Behav Brain Res; 2019 Nov; 374():112113. PubMed ID: 31381976
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protease-activated receptor 2-mediated protection of myocardial ischemia-reperfusion injury: role of transient receptor potential vanilloid receptors.
    Zhong B; Wang DH
    Am J Physiol Regul Integr Comp Physiol; 2009 Dec; 297(6):R1681-90. PubMed ID: 19812353
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Overexpression of long or short FGFR-1 results in FGF-2-mediated proliferation in neonatal cardiac myocyte cultures.
    Sheikh F; Fandrich RR; Kardami E; Cattini PA
    Cardiovasc Res; 1999 Jun; 42(3):696-705. PubMed ID: 10533610
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Elimination of endogenous high molecular weight FGF2 prevents pressure-overload-induced systolic dysfunction, linked to increased FGFR1 activity and NR1D1 expression.
    Koleini N; Nickel BE; Nagalingam RS; Landry NM; Fandrich RR; Cheung DYC; Dixon IM; Czubryt MP; Jassal DS; Cattini PA; Kardami E
    Cell Tissue Res; 2021 Sep; 385(3):753-768. PubMed ID: 34057573
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Cardiac Mitochondrial FGFR1 Mediates the Antithetical Effects of FGF2 Isoforms on Permeability Transition.
    Srisakuldee W; Nickel BE; Fandrich RR; Zhang F; Pasumarthi KBS; Kardami E
    Cells; 2021 Oct; 10(10):. PubMed ID: 34685716
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nuclear translocation of fibroblast growth factor-2 (FGF2) is regulated by Karyopherin-β2 and Ran GTPase in human glioblastoma cells.
    Wang F; Yang L; Shi L; Li Q; Zhang G; Wu J; Zheng J; Jiao B
    Oncotarget; 2015 Aug; 6(25):21468-78. PubMed ID: 26056081
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nuclear localization of mouse fibroblast growth factor 2 requires N-terminal and C-terminal sequences.
    Foletti A; Vuadens F; Beermann F
    Cell Mol Life Sci; 2003 Oct; 60(10):2254-65. PubMed ID: 14618271
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased High Molecular Weight FGF2 in Endocrine-Resistant Breast Cancer.
    Sahores A; Figueroa V; May M; Liguori M; Rubstein A; Fuentes C; Jacobsen BM; Elía A; Rojas P; Sequeira GR; Álvarez MM; González P; Gass H; Hewitt S; Molinolo A; Lanari C; Lamb CA
    Horm Cancer; 2018 Oct; 9(5):338-348. PubMed ID: 29956066
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel cardioprotective role of a small heat-shock protein, Hsp20, against ischemia/reperfusion injury.
    Fan GC; Ren X; Qian J; Yuan Q; Nicolaou P; Wang Y; Jones WK; Chu G; Kranias EG
    Circulation; 2005 Apr; 111(14):1792-9. PubMed ID: 15809372
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low-molecular-weight fibroblast growth factor 2 attenuates hepatic fibrosis by epigenetic down-regulation of Delta-like1.
    Pan RL; Xiang LX; Wang P; Liu XY; Nie L; Huang W; Shao JZ
    Hepatology; 2015 May; 61(5):1708-20. PubMed ID: 25501710
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The protective effect of trimetazidine on myocardial ischemia/reperfusion injury through activating AMPK and ERK signaling pathway.
    Liu Z; Chen JM; Huang H; Kuznicki M; Zheng S; Sun W; Quan N; Wang L; Yang H; Guo HM; Li J; Zhuang J; Zhu P
    Metabolism; 2016 Mar; 65(3):122-30. PubMed ID: 26892523
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Macrophage migration inhibitory factor plays an essential role in ischemic preconditioning-mediated cardioprotection.
    Ruze A; Chen BD; Liu F; Chen XC; Gai MT; Li XM; Ma YT; Du XJ; Yang YN; Gao XM
    Clin Sci (Lond); 2019 Mar; 133(5):665-680. PubMed ID: 30804219
    [TBL] [Abstract][Full Text] [Related]  

  • 40. H(mox-1) constitutes an adaptive response to effect antioxidant cardioprotection: A study with transgenic mice heterozygous for targeted disruption of the Heme oxygenase-1 gene.
    Yoshida T; Maulik N; Ho YS; Alam J; Das DK
    Circulation; 2001 Mar; 103(12):1695-701. PubMed ID: 11273999
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.